Crossmark

Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke

Crossref DOI link: https://doi.org/10.1007/s13311-022-01203-0

Published Print: 2022-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Simats, Alba

Ramiro, Laura

Valls, Raquel

de Ramón, Helena

García-Rodríguez, Paula

Orset, Cyrille

Artigas, Laura

Sardon, Teresa

Rosell, Anna

Montaner, Joan https://orcid.org/0000-0001-9796-2422
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (PI15/00354)

Instituto de Salud Carlos III (PI18/00804)

Instituto de Salud Carlos III (RD16/0019/0021)

Instituto de Salud Carlos III (IFI17/00012)

Generalitat de Catalunya (2017-SGR-1427)

Consejería de Salud, Junta de Andalucía (PE-0527-2019)
License Information

Text and Data Mining valid from 2022-03-01

Text and Data Mining valid from 2022-03-01

Version of Record valid from 2023-08-21
More Information

This article is maintained by: Elsevier

Article Title: Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-022-01203-0

Content Type: article

Copyright: Copyright © 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.